GO:0070095 fructose-6-phosphate binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070095 (fructose-6-phosphate binding) is a molecular function defined as binding to fructose 6-phosphate, a central metabolite in glycolysis and the pentose phosphate pathway.
• Key proteins that bind fructose 6-phosphate include phosphofructokinase (PFK), 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB), and the glucokinase regulatory protein (GKRP).
• Fructose 6-phosphate binding is critical for allosteric regulation of glycolysis and glucose homeostasis, with mutations altering enzyme activity and phosphate activation.
• Dysregulation of fructose 6-phosphate-binding proteins is linked to metabolic disorders, cancer, and ER stress-related diseases.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise dissection of fructose 6-phosphate binding sites and their physiological roles.
• Studying this term requires integrating structural biology, enzymology, and functional genomics to understand its role in health and disease.
Description
Fructose 6-phosphate binding (GO:0070095) is a molecular function that mediates the interaction of proteins with fructose 6-phosphate, a key intermediate in glycolysis and the pentose phosphate pathway. This binding event is essential for the regulation of several metabolic enzymes, including phosphofructokinase and the bifunctional enzyme 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase, which control glycolytic flux and glucose homeostasis. Researchers study this term to understand how cells sense and respond to metabolic cues, and how mutations in binding sites contribute to disease. The specificity of fructose 6-phosphate binding is determined by conserved residues in the active sites of these enzymes, as revealed by site-directed mutagenesis and crystallographic studies. Given its central role in metabolism, fructose 6-phosphate binding is a target for investigating metabolic disorders, cancer, and developmental defects.
fructose-6-phosphate binding At A Glance
| GO ID | GO:0070095 |
|---|---|
| GO term | fructose-6-phosphate binding |
| Ontology | molecular_function |
| Synonym | D-fructose 6-phosphate binding, fructose 6-phosphate binding |
| Major function | Binding to fructose 6-phosphate, a key metabolite in glycolysis and pentose phosphate pathway |
| Representative proteins | Phosphofructokinase, 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase, glucokinase regulatory protein |
| Related processes | Glycolysis, gluconeogenesis, pentose phosphate pathway, allosteric regulation |
| Disease relevance | Metabolic disorders, cancer, ER stress-related diseases |
What Is GO:0070095?
Fructose-6-phosphate binding (GO:0070095) is the molecular function of selectively interacting with fructose 6-phosphate, a six-carbon sugar phosphate. This binding typically occurs in the active sites or regulatory domains of enzymes and regulatory proteins, enabling catalysis, allosteric regulation, or signal transduction.
Why Is fructose-6-phosphate binding Important in Cell Biology?
Fructose 6-phosphate binding is fundamental to cellular energy metabolism because it controls the activity of rate-limiting enzymes in glycolysis and the pentose phosphate pathway. This binding event allows cells to rapidly adjust metabolic flux in response to changing nutrient availability, and its dysregulation is implicated in diseases such as diabetes, cancer, and developmental disorders. Understanding the structural and functional basis of fructose 6-phosphate binding provides insights into metabolic regulation and offers potential therapeutic targets.
• Regulates glycolytic flux through allosteric control of phosphofructokinase.
• Modulates the bifunctional enzyme PFKFB, which controls fructose-2,6-bisphosphate levels and glycolysis.
• Influences glucokinase activity via the regulatory protein GKRP, affecting glucose sensing in liver.
• Mutations in fructose 6-phosphate-binding sites alter enzyme kinetics and phosphate activation.
• Linked to ER stress and misfolded protein accumulation in muscle-specific Gfpt1 deficiency.
• Provides a target for studying metabolic reprogramming in cancer.
• Essential for understanding sugar phosphate sensing and signaling.
• Enables structure-based design of inhibitors or activators for metabolic diseases.
Molecular Mechanism of fructose-6-phosphate binding
Substrate Recognition and Binding Site Architecture
In simple terms: Proteins have specific pockets that fit fructose 6-phosphate like a lock and key.
Fructose 6-phosphate binds to conserved active-site residues in enzymes such as phosphofructokinase and PFKFB. Structural studies and mutagenesis have identified key residues that interact with the phosphate and hydroxyl groups of fructose 6-phosphate, determining substrate specificity and affinity. For example, in the regulatory protein of glucokinase, residues involved in fructose 6-phosphate binding were mapped by site-directed mutagenesis.
Allosteric Regulation and Conformational Changes
In simple terms: Binding can change the shape of the protein, turning its activity up or down.
In phosphofructokinase, fructose 6-phosphate binding induces conformational changes that promote catalysis and allosteric activation. MgATP and fructose 6-phosphate interactions with E. coli phosphofructokinase have been characterized, showing cooperative binding and regulation. Similarly, in PFKFB, fructose 6-phosphate binding to the 2-kinase domain is modulated by citrate and other effectors.
Catalytic Mechanism and Transition State
In simple terms: Once bound, fructose 6-phosphate is converted into another molecule as part of a chemical reaction.
The binding of fructose 6-phosphate positions the substrate for phosphorylation by ATP in phosphofructokinase, leading to fructose 1,6-bisphosphate formation. The epimeric specificity of the fructose 6-phosphate site in phosphofructokinase has been studied, revealing strict stereochemical requirements. In PFKFB, the 2-kinase domain catalyzes phosphorylation of fructose 6-phosphate to fructose 2,6-bisphosphate, a potent glycolytic activator.
Regulation by Metabolites and Post-translational Modifications
In simple terms: Other molecules can enhance or block the binding of fructose 6-phosphate.
Fructose 6-phosphate binding is regulated by cellular metabolites such as citrate, which inhibits substrate binding in PFKFB2. Additionally, mutations at the fructose 6-phosphate binding site in rat liver 6-phosphofructo-2-kinase affect phosphate activation, indicating that binding is coupled to phosphate sensing. In glucokinase regulatory protein, sorbitol 6-phosphate and fructose 1-phosphate compete with fructose 6-phosphate for binding, modulating glucokinase activity.
Key Genes Involved in GO:0070095 fructose-6-phosphate binding
The following genes encode proteins that bind fructose 6-phosphate and are central to metabolic regulation and disease.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PFKM | Muscle phosphofructokinase; catalyzes fructose 6-phosphate phosphorylation | Glycolysis regulation, glycogen storage disease type VII |
| PFKL | Liver phosphofructokinase; key regulatory enzyme in glycolysis | Metabolic disorders, cancer metabolism |
| PFKP | Platelet phosphofructokinase; controls glycolytic flux | Cancer cell proliferation |
| PFKFB1 | Bifunctional enzyme; synthesizes fructose 2,6-bisphosphate | Glucose homeostasis, diabetes |
| PFKFB2 | Heart isoform; regulated by citrate and fructose 6-phosphate | Cardiac metabolism, ischemic heart disease |
| PFKFB3 | Inducible isoform; promotes glycolysis | Cancer, inflammation |
| PFKFB4 | Testis isoform; regulates glycolysis | Cancer, spermatogenesis |
| GCKR | Glucokinase regulatory protein; binds fructose 6-phosphate | Type 2 diabetes, hypertriglyceridemia |
| GFPT1 | Glutamine-fructose-6-phosphate transaminase 1; uses fructose 6-phosphate | ER stress, myasthenic syndrome |
| GFPT2 | Glutamine-fructose-6-phosphate transaminase 2 | Cancer, fibrosis |
| G6PD | Glucose-6-phosphate dehydrogenase; indirect link via pentose phosphate pathway | Hemolytic anemia, cancer |
| HXK1 | Hexokinase 1; phosphorylates glucose to glucose 6-phosphate | Glycolysis, cancer |
| HXK2 | Hexokinase 2; binds fructose 6-phosphate as product | Cancer, metabolic reprogramming |
| ALDOA | Aldolase A; cleaves fructose 1,6-bisphosphate | Glycolysis, cancer |
| TPI1 | Triosephosphate isomerase; downstream of fructose 6-phosphate | Glycolysis, neurodegeneration |
| PKM | Pyruvate kinase; final step of glycolysis | Cancer, metabolic disorders |
| GAPDH | Glyceraldehyde-3-phosphate dehydrogenase; glycolytic enzyme | Glycolysis, apoptosis |
How Is fructose-6-phosphate binding Regulated?
Fructose 6-phosphate binding is regulated by cellular energy status and metabolite levels. For example, citrate inhibits fructose 6-phosphate binding to PFKFB2, reducing fructose 2,6-bisphosphate synthesis and glycolytic flux. In glucokinase regulatory protein, fructose 6-phosphate binding is competed by sorbitol 6-phosphate and fructose 1-phosphate, linking binding to polyol pathway activity. Additionally, mutations at the fructose 6-phosphate binding site in PFKFB affect phosphate activation, suggesting crosstalk between phosphate sensing and substrate binding. These regulatory mechanisms ensure that glycolysis is finely tuned to cellular demands.
fructose-6-phosphate binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GCKR | Type 2 diabetes, hypertriglyceridemia | Knock-in mouse with point mutation in fructose 6-phosphate binding site |
| PFKFB3 | Cancer (glycolytic addiction) | Knockout or overexpression in cancer cell lines |
| GFPT1 | ER stress, myasthenic syndrome | Muscle-specific knockout mouse |
| PFKM | Glycogen storage disease type VII | Point mutation knock-in in muscle cells |
| PFKFB2 | Cardiac ischemia | Heart-specific knockout or point mutation |
Metabolic Disorders and Diabetes
Dysregulation of fructose 6-phosphate binding proteins is associated with metabolic diseases. Mutations in GCKR, which encodes the glucokinase regulatory protein, alter fructose 6-phosphate binding and are linked to type 2 diabetes and hypertriglyceridemia. Similarly, PFKFB isoforms are implicated in glucose homeostasis, and their altered activity contributes to insulin resistance.
Cancer Metabolism
Cancer cells often exhibit increased glycolysis (Warburg effect), and fructose 6-phosphate binding enzymes such as PFKFB3 and PFKP are overexpressed in various tumors. Targeting these enzymes or their binding sites is a potential therapeutic strategy.
ER Stress and Myopathies
Muscle-specific lack of Gfpt1, which utilizes fructose 6-phosphate, triggers ER stress and alleviates misfolded protein accumulation, linking fructose 6-phosphate metabolism to protein quality control and muscle function.
From fructose-6-phosphate binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of fructose 6-phosphate binding affect glycolysis? | Knockout of PFKFB3 or PFKM in cell lines |
| How do point mutations in the binding site alter enzyme kinetics? | Point mutation knock-in (e.g., GCKR, PFKFB1) |
| Can a tagged version track binding dynamics? | Knock-in of fluorescent tag (e.g., GFP) at endogenous locus |
| Does overexpression of PFKFB3 promote cancer growth? | Overexpression in cancer cell lines or xenografts |
| What is the role of GFPT1 in ER stress? | Muscle-specific knockout or overexpression |
| Can CRISPR screening identify modifiers of fructose 6-phosphate binding? | Genome-wide CRISPR library screening |
How to Study the fructose-6-phosphate binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| X-ray crystallography | 3D structure of protein-ligand complex | Mapping fructose 6-phosphate binding site |
| Isothermal titration calorimetry | Binding affinity (Kd) | Quantifying fructose 6-phosphate binding |
| Enzyme kinetics | Catalytic activity and inhibition | Assessing mutant enzyme function |
| CRISPR knockout | Loss-of-function phenotype | Studying gene essentiality |
| CRISPR point mutation | Effect of specific residue change | Dissecting binding site residues |
| Metabolomics | Metabolite levels | Measuring pathway flux |
| RNA-seq | Transcriptional changes | Identifying compensatory pathways |
Structural Biology (X-ray Crystallography and Cryo-EM)
Crystal structures of enzymes bound to fructose 6-phosphate, such as PFKFB2, reveal the atomic details of binding and conformational changes. These methods identify key residues and guide mutagenesis studies.
Enzymatic Assays and Kinetics
Kinetic assays measure binding affinity (Kd) and catalytic activity (kcat/Km) of wild-type and mutant proteins. For example, site-directed mutagenesis of the fructose 6-phosphate binding site in PFKFB affects phosphate activation.
CRISPR-Cas9 Genome Editing
CRISPR knockout, point mutation, and knock-in models enable functional studies of fructose 6-phosphate binding proteins in cells and organisms. Muscle-specific Gfpt1 knockout revealed ER stress phenotypes.
Metabolomics and Flux Analysis
Mass spectrometry-based metabolomics quantifies fructose 6-phosphate and downstream metabolites, providing insights into pathway flux and regulation.
How CRISPR Can Be Used to Study GO:0070095 fructose-6-phosphate binding
Knockout
CRISPR knockout of genes encoding fructose 6-phosphate-binding proteins (e.g., PFKFB3, GFPT1) allows researchers to assess loss-of-function phenotypes, such as altered glycolysis, cell growth, or ER stress.
Point Mutation
Introducing precise point mutations in the fructose 6-phosphate binding site (e.g., in GCKR or PFKFB1) via CRISPR base editing or HDR enables dissection of specific residues required for binding and regulation.
Knock-in
Knock-in of tagged versions (e.g., GFP, FLAG) at endogenous loci allows real-time tracking of protein localization and binding dynamics without overexpression artifacts.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of fructose 6-phosphate-binding enzymes (e.g., PFKFB3) can model cancer metabolic reprogramming and identify downstream effects.
How EDITGENE Supports fructose-6-phosphate binding Research
Researchers studying fructose-6-phosphate binding-related genes often need to determine whether a candidate gene is causally involved in metabolic regulation or disease. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models, enabling functional validation of binding sites and pathways.
Contact EDITGENE today to design your custom CRISPR model for fructose-6-phosphate binding research.
Frequently Asked Questions About fructose-6-phosphate binding
What is fructose-6-phosphate binding?
Fructose-6-phosphate binding (GO:0070095) is a molecular function where a protein selectively binds to fructose 6-phosphate, a key metabolite in glycolysis and the pentose phosphate pathway.
What genes are involved in fructose-6-phosphate binding?
Key genes include PFKM, PFKL, PFKP, PFKFB1-4, GCKR, and GFPT1/2, which encode enzymes and regulatory proteins that bind fructose 6-phosphate.
How is fructose-6-phosphate binding regulated?
It is regulated by metabolites such as citrate, which inhibits binding to PFKFB2, and by phosphate activation through mutations in the binding site.
What diseases are associated with fructose-6-phosphate binding?
Dysregulation is linked to type 2 diabetes, cancer, ER stress-related myopathies, and glycogen storage diseases.
What methods are used to study fructose-6-phosphate binding?
Common methods include X-ray crystallography, isothermal titration calorimetry, enzyme kinetics, CRISPR genome editing, and metabolomics.
Can CRISPR be used to study fructose-6-phosphate binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise functional studies of binding sites and pathways.
What is the role of PFKFB3 in fructose-6-phosphate binding?
PFKFB3 binds fructose 6-phosphate in its 2-kinase domain to produce fructose 2,6-bisphosphate, promoting glycolysis in cancer cells.
How does GCKR bind fructose 6-phosphate?
The glucokinase regulatory protein (GCKR) binds fructose 6-phosphate through specific residues identified by mutagenesis, modulating glucokinase activity.
What is the clinical relevance of fructose-6-phosphate binding?
It is central to metabolic regulation and represents a target for therapeutic intervention in diabetes, cancer, and metabolic disorders.
Where can I find CRISPR models for fructose-6-phosphate binding research?
EDITGENE provides custom knockout, point mutation, knock-in, and overexpression cell models for genes involved in fructose-6-phosphate binding.
Conclusion
Fructose-6-phosphate binding (GO:0070095) is a fundamental molecular function that governs key metabolic enzymes and regulatory proteins. Its precise regulation is essential for normal physiology, and its dysregulation contributes to a range of diseases, including diabetes and cancer. Advances in CRISPR genome editing and structural biology continue to unravel the mechanistic details of this binding event, offering new opportunities for therapeutic development. EDITGENE supports these efforts with tailored CRISPR models and bioinformatics services.
References
- 1. Vandercammen A et al.. 1992. Binding of sorbitol 6-phosphate and of fructose 1-phosphate to the regulatory protein of liver glucokinase.. Biochem J 286 ( Pt 1)(Pt 1):253-6 PMID: 1520277
- 2. Johnson JL et al.. 1992. MgATP and fructose 6-phosphate interactions with phosphofructokinase from Escherichia coli.. Biochemistry 31(46):11510-8 PMID: 1445885
- 3. Veiga-da-Cunha M et al.. 2002. Identification of fructose 6-phosphate- and fructose 1-phosphate-binding residues in the regulatory protein of glucokinase.. J Biol Chem 277(10):8466-73 PMID: 11756407
- 4. Zhang R et al.. 2024. Muscle-specific lack of Gfpt1 triggers ER stress to alleviate misfolded protein accumulation.. Dis Model Mech 17(8) PMID: 38903011
- 5. Crochet RB et al.. 2017. Crystal structure of heart 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB2) and the inhibitory influence of citrate on substrate binding.. Proteins 85(1):117-124 PMID: 27802586
- 6. Koerner TA Jr et al.. 1976. The fructose 6-phosphate site of phosphofructokinase. Epimeric specificity.. J Biol Chem 251(10):2983-6 PMID: 131802
- 7. Bertrand L et al.. 1998. Mutagenesis of the fructose-6-phosphate-binding site in the 2-kinase domain of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase.. Eur J Biochem 254(3):490-6 PMID: 9688258
- 8. Li L et al.. 1992. Site-directed mutagenesis in rat liver 6-phosphofructo-2-kinase. Mutation at the fructose 6-phosphate binding site affects phosphate activation.. J Biol Chem 267(7):4386-93 PMID: 1311308
